B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

“…Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”

Planning performance decreases with decreasing oscillation frequency and is worst for a solitary wave. by Azadeh Khajeh-Alijani (767689)

The ratio of standard deviation to mean dose (SD/mean) decreases with neuronal dose. by Murat Alp (781371)

TL decreases cell viability in malignant cells dependent of p53 status. by Ajay Kumar (192967)

Inhibition of Src family kinases decreases cell migration and phosphorylation of caveolin-1 on tyrosine-14. (A) by Hery Urra (172534)

WNT3 decreases GCP proliferation by inhibiting SHH dependent gene transcription. by Sandrine L. Anne (489755)

“…<p>(<i>A</i>) WNT3 decreased proliferation of GCPs by 40.3± 5.0% of the control (Con) (n=3) as measured by [³H]-Thymidine incorporation assay. …”

Genetic and pharmacologic inhibition of TTK decrease growth of PDAC cell lines. by Jeran K. Stratford (187175)

Glucose inhibition decreases IL-1β levels and tumor progression in the B16F10 mouse model. by Yunseo Woo (6157307)

Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study by Jon Jarløv Rasmussen (2993427)

“…Current AAS abusers exhibited severely decreased AMH and inhibin B indicative of impaired spermatogenesis.…”

Systemic inhibition of CSF-1R decreases B16F10-induced accumulation of blood monocyte subsets. by Marjolein Sluijter (613087)

Subjects:

Variable importance plot (mean decrease accuracy and mean decrease Gini). by Fernando Martinez-Taboada (8655132)

MK-STYX decreases RhoA activation. by Brittany M. Flowers (670483)

Decreased remyelination initiation is observed in Scribble cKO mice following focal demyelination in corpus callosum. by Andrew A. Jarjour (343100)

“…<i>n</i> = 3 mice per genotype. * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001 versus Scrib WT CL. Scale bars: A,B,D,E: 2 μm. J,K: 50 μm.</p>…”

Binding of compound 16 with DNA-Topo II complex. by Ahmed A. Gaber (13302308)

Subjects:

General procedure for the synthesis of the target compounds 16–20. by Ahmed A. Gaber (13302308)

Subjects:

Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

“…D) Fenretinide did not decrease mRNA levels of FOXO1 in aRMS cells. qRT–PCR was carried out after treatment with an IC₅₀ concentration of fenretinide during different time points (24–48–72 hours). …”

Trehalose improved cell glucose consumption and decreased MDA content of cryopreserved valve cells. by Hongyan Wu (302636)

LPLI decreases the transcription activity of NFκB. by Jyun-Yi Wu (103136)

IκBαM.1-Infected Mice Have Decreased Latency in Lung B Cells 16 dpi after Intranasal Infection by Laurie T Krug (68237)

nLTD decreases the molecular proximity between endogenous spine cofilin and F-actin by Barbara Calabrese (553229)